Brigitte de Vet-Veithen
Brigitte de Vet-Veithen leads Materialise as CEO, overseeing the company's global operations across 3D printing software and manufacturing services. She took the helm of one of Belgium's most internationally recognised technology companies, guiding strategy for its medical, industrial, and consumer segments.
As CEO of Materialise, Brigitte steers the strategic direction of a NASDAQ-listed company operating at the intersection of software, manufacturing, and medical technology across more than 20 countries.
Career
Roles
Materialise#25factoryCEO MaterialiseJan 2024 – Present
- CAPRICORN HEALTH-TECH FUNDChairwoman of the BoardFeb 2018 – Present
- Healthcare and Life Science Executive at De Vet ManagementCTO and transformation lead at Mediq2013 – 2015
- Healthcare and Life Science Executive at De Vet ManagementCEO of Acertys group2011 – 2013
- Healthcare and Life Science Executive at De Vet ManagementGlobal portfolio & project management and Business Intelligence at GSK Bio2009 – 2011
- Healthcare and Life Science Executive at De Vet ManagementR&D program manager at Crucell2008 – 2009
- Healthcare and Life Science Executive at De Vet ManagementCEO of Monitor-IT (mobile health, spin-off from research center)2007 – 2008
- Johnson and Johnson MD&DGeneral Manager Germany2004 – 2007
- Johnson and Johnson MD&DVP EMEA2002 – 2004
- Johnson and Johnson MD&DBusiness Director UK2000 – 2002
- Johnson and Johnson MD&DEuropean Manager New Business Development1999 – 2000
- Andersen ConsultingSenior Consultant1996 – 1999
- DGM (Deutsche Bank / Roland Berger)Consultant1993 – 1996
From public career histories · 18 entries